大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/12/21 | 4,274 | 4,283 | 4,232 | 4,247 | +43 | +1% | 673,500 |
2021/12/20 | 4,202 | 4,235 | 4,193 | 4,204 | -10 | -0.2% | 615,800 |
2021/12/17 | 4,232 | 4,278 | 4,214 | 4,214 | -62 | -1.4% | 1,385,800 |
2021/12/16 | 4,250 | 4,279 | 4,228 | 4,276 | +94 | +2.2% | 906,700 |
2021/12/15 | 4,173 | 4,204 | 4,158 | 4,182 | +16 | +0.4% | 746,400 |
2021/12/14 | 4,129 | 4,169 | 4,125 | 4,166 | +58 | +1.4% | 913,400 |
2021/12/13 | 4,140 | 4,155 | 4,103 | 4,108 | +14 | +0.3% | 656,400 |
2021/12/10 | 4,128 | 4,144 | 4,082 | 4,094 | -45 | -1.1% | 1,112,800 |
2021/12/09 | 4,177 | 4,194 | 4,138 | 4,139 | -35 | -0.8% | 799,600 |
2021/12/08 | 4,174 | 4,198 | 4,146 | 4,174 | +33 | +0.8% | 1,060,700 |
2021/12/07 | 4,100 | 4,164 | 4,047 | 4,141 | +91 | +2.2% | 1,244,700 |
2021/12/06 | 4,076 | 4,093 | 4,050 | 4,050 | -22 | -0.5% | 793,100 |
2021/12/03 | 4,046 | 4,083 | 4,012 | 4,072 | +36 | +0.9% | 1,055,300 |
2021/12/02 | 4,040 | 4,096 | 4,029 | 4,036 | -15 | -0.4% | 1,106,300 |
2021/12/01 | 4,051 | 4,121 | 4,040 | 4,051 | -95 | -2.3% | 1,915,600 |
2021/11/30 | 4,065 | 4,146 | 4,062 | 4,146 | +116 | +2.9% | 4,634,100 |
2021/11/29 | 4,043 | 4,080 | 4,017 | 4,030 | -59 | -1.4% | 1,714,400 |
2021/11/26 | 4,128 | 4,138 | 4,057 | 4,089 | -80 | -1.9% | 1,713,900 |
2021/11/25 | 4,141 | 4,180 | 4,111 | 4,169 | +25 | +0.6% | 1,086,200 |
2021/11/24 | 4,179 | 4,191 | 4,126 | 4,144 | -14 | -0.3% | 1,349,600 |
2021/11/22 | 4,091 | 4,172 | 4,088 | 4,158 | +42 | +1% | 1,363,700 |
2021/11/19 | 4,111 | 4,142 | 4,091 | 4,116 | -19 | -0.5% | 2,150,200 |
2021/11/18 | 4,155 | 4,168 | 4,116 | 4,135 | -55 | -1.3% | 1,186,400 |
2021/11/17 | 4,256 | 4,280 | 4,190 | 4,190 | -69 | -1.6% | 1,060,400 |
2021/11/16 | 4,271 | 4,320 | 4,257 | 4,259 | -10 | -0.2% | 1,099,800 |
2021/11/15 | 4,340 | 4,386 | 4,268 | 4,269 | -23 | -0.5% | 1,268,700 |
2021/11/12 | 4,401 | 4,456 | 4,268 | 4,292 | -103 | -2.3% | 2,153,100 |
2021/11/11 | 4,410 | 4,430 | 4,378 | 4,395 | -48 | -1.1% | 654,100 |
2021/11/10 | 4,425 | 4,472 | 4,422 | 4,443 | -5 | -0.1% | 509,100 |
2021/11/09 | 4,484 | 4,528 | 4,445 | 4,448 | -51 | -1.1% | 644,400 |
2021/11/08 | 4,535 | 4,549 | 4,490 | 4,499 | -61 | -1.3% | 691,200 |
2021/11/05 | 4,579 | 4,588 | 4,531 | 4,560 | -36 | -0.8% | 566,900 |
2021/11/04 | 4,648 | 4,648 | 4,568 | 4,596 | +15 | +0.3% | 872,900 |
2021/11/02 | 4,584 | 4,620 | 4,564 | 4,581 | -39 | -0.8% | 705,400 |
2021/11/01 | 4,564 | 4,643 | 4,531 | 4,620 | +126 | +2.8% | 1,180,000 |
2021/10/29 | 4,530 | 4,531 | 4,441 | 4,494 | -25 | -0.6% | 697,400 |
2021/10/28 | 4,580 | 4,599 | 4,519 | 4,519 | -127 | -2.7% | 821,700 |
2021/10/27 | 4,649 | 4,673 | 4,630 | 4,646 | -7 | -0.2% | 483,800 |
2021/10/26 | 4,636 | 4,692 | 4,618 | 4,653 | +60 | +1.3% | 628,000 |
2021/10/25 | 4,616 | 4,645 | 4,593 | 4,593 | -55 | -1.2% | 643,200 |
2021/10/22 | 4,618 | 4,686 | 4,618 | 4,648 | -4 | -0.1% | 664,500 |
2021/10/21 | 4,729 | 4,737 | 4,639 | 4,652 | -73 | -1.5% | 603,600 |
2021/10/20 | 4,720 | 4,762 | 4,697 | 4,725 | +7 | +0.1% | 608,200 |
2021/10/19 | 4,771 | 4,817 | 4,718 | 4,718 | -82 | -1.7% | 566,500 |
2021/10/18 | 4,847 | 4,849 | 4,784 | 4,800 | -50 | -1% | 607,500 |
2021/10/15 | 4,837 | 4,867 | 4,821 | 4,850 | +28 | +0.6% | 722,000 |
2021/10/14 | 4,780 | 4,835 | 4,743 | 4,822 | +40 | +0.8% | 720,000 |
2021/10/13 | 4,759 | 4,817 | 4,753 | 4,782 | -4 | -0.1% | 468,300 |
2021/10/12 | 4,821 | 4,843 | 4,772 | 4,786 | -54 | -1.1% | 586,400 |
2021/10/11 | 4,776 | 4,865 | 4,758 | 4,840 | +5 | +0.1% | 840,500 |
901~
950
件表示中 / 3596件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 789,300円 | +2.2% | +28.0% | 1.77% | 12.63倍 | 1.53倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
武 田 | 440,200円 | -1.1% | +75.3% | 4.54% | 30.49倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
第一三共 | 358,800円 | +6.0% | +4.0% | 2.17% | 22.14倍 | 4.09倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
アステラス薬 | 162,900円 | +0.9% | +380.2% | 4.79% | 22.44倍 | 1.93倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 254,000円 | +20.9% | +10.6% | 2.60% | 12.01倍 | 1.59倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム